Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLOT3: FLOT Regimen in Gastric and GEJ Adenocarcinoma
NCT00849615Phase 2Completed
- Sponsor
- Krankenhaus Nordwest
- Start
- Feb 2009
- Primary completion
- Jan 2012
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, fluorouracil, oxaliplatin, folinic acid in gastric cancer (GC), adenocarcinoma of the esophagogastric junction (AEG), sponsored by Krankenhaus Nordwest. Started Feb 2009; status: completed.
02
Drugs
docetaxelfluorouraciloxaliplatinfolinic acid
03
Conditions
gastric cancer (GC)adenocarcinoma of the esophagogastric junction (AEG)
Beyond the preview
Go deeper on NCT00849615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00849615.